⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNY News
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
Press release: Availability of the Q1 2026 aide-mémoire
globenewswire.com
SNY
Dupixent® (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP)
globenewswire.com
SNY
REGN
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid
globenewswire.com
REGN
SNY
Damora Therapeutics Appoints Biotechnology Leader Jennifer Jarrett as President and Chief Executive Officer; Adds Two Industry Veterans to Board of Directors
globenewswire.com
DMRA
RCUS
UBER
PFE
SNY
ALGT
IPHA
GMED
Kali Therapeutics Announces Worldwide Exclusive License Agreement with Sanofi for Next-Generation Tri-Specific T-Cell Engager for Autoimmune Diseases
prnewswire.com
SNY
Anaveon appoints Biotech Leader Thaminda Ramanayake as Chief Executive Officer
globenewswire.com
CVAC
BNTX
SNY
AMGN
NVS
PFE
Earendil Labs Announces $787 Million in Financing to Scale AI-Driven Biologics Discovery and Development
prnewswire.com
SNY
PFE
Inhibrx Reports Fourth Quarter and Fiscal Year 2025 Financial Results
prnewswire.com
INBX
SNY
Bleeding.org LIVE! is the First Celebrity-Driven National Event for the Bleeding Disorders Community
prnewswire.com
SNY
PFE
Mirecule Expands Strategic FSHD Collaboration with Sanofi
businesswire.com
SNY